KIMBERLEE SLIGER: Open Payments
NPI 1306288436 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 19 payments from 8 companies in 2025. Trend: 2023 $282 · 2024 $497 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $64 |
| ABBVIE INC. | 3 | $58 |
| PFIZER INC. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Dynavax Technologies Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: PAXLOVID, Kerendia, OTEZLA, VRAYLAR, UBRELVY, Heplisav-B, REXULTI, EVENITY.
Industry payments across KY — which companies pay providers there.
